Experience with sirolimus for calcineurin minimization/elimination in pancreas-after-kidney transplantation

Transplant Proc. 2005 Oct;37(8):3542-3. doi: 10.1016/j.transproceed.2005.09.042.

Abstract

Pancreas after kidney (PAK) transplantation, associated with a persistent elevation in serum creatinine (defined as a >25% increase from baseline), was seen in 7 of 11 (64%) cases maintained on immunosuppressive therapy consisting of tacrolimus, mycophenolate mofetil, and prednisone. Patients were converted to sirolimus as a means of minimizing or eliminating exposure to tacrolimus, the presumed nephrotoxic agent. With the use of sirolimus-based immunosuppression, and with elimination or minimization of tacrolimus, renal function, as measured by serum creatinine, stabilized or improved in all cases.

MeSH terms

  • Creatinine / blood
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Function Tests
  • Kidney Transplantation / immunology*
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Pancreas Transplantation / immunology*
  • Prednisone / therapeutic use
  • Retrospective Studies
  • Sirolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Creatinine
  • Mycophenolic Acid
  • Prednisone
  • Sirolimus